Abstract
Ataxia encompasses a large group of rare disorders characterized by irregular movements, decreased coordination, imbalance, kinetic tremor, wide-based stance, and dysarthria. Evaluating ataxia can be challenging considering the volume of disorders and their complex pathologies involving diverse genetic and clinical factors. This is a comprehensive review of the genetic ataxia literature, presenting updated guidelines for differential diagnosis. Age, time course, and family history provide initial guidance for evaluation of ataxia. As genetic testing is increasingly utilized, new genes are discovered and phenotypes for existing disorders are expanded. This review assists physicians by offering a diagnostic roadmap for suspected hereditary ataxia based on the current literature.
Similar content being viewed by others
References
Schols L, Szymanski S, Peters S, Przuntek H, Epplen JT, Hardt C, et al. Genetic background of apparently idiopathic sporadic cerebellar ataxia. Hum Genet. 2000;107(2):132–7.
Hadjivassiliou M, Martindale J, Shanmugarajah P, Grunewald RA, Sarrigiannis PG, Beauchamp N, et al. Causes of progressive cerebellar ataxia: prospective evaluation of 1500 patients. J Neurol Neurol Neurosurg Psychiatry. 2017;88(4):301–9.
Horton RH, Lucassen AM. Recent developments in genetic/genomic medicine. Clin Scie (Lond). 2019;133(5):697–708.
Sun M, Johnson AK, Nelakuditi V, Guidugli L, Fischer D, Arndt K, et al. Targeted exome analysis identifies the genetic basis of disease in over 50% of patients with a wide range of ataxia-related phenotypes. Genet Med. 2019;21(1):195–206.
Brandsma R, Verschuuren-Bemelmans CC, Amrom D, Barisic N, Baxter P, Bertini E, et al. A clinical diagnostic algorithm for early onset cerebellar ataxia. Eur J Paediatr Neurol. 2019;23(5):692–706.
Adam MP AH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle: University of Washington, Seattle 1993–2020.
Evidente VG, Gwinn-Hardy KA, Caviness JN, Gilman S. Hereditary ataxias. Mayo Clinic Proc. 2000;75(5):475–90.
Rasmussen A, Gomez M, Alonso E, Bidichandani SI. Clinical heterogeneity of recessive ataxia in the Mexican population. J Neurol Neurol Neurosurg Psychiatry. 2006;77(12):1370–2.
Cortese A, Simone R. Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia. Nat Genet. 2019;51(4):649–58.
Infante J, Garcia A, Serrano-Cardenas KM, Gonzalez-Aguado R, Gazulla J, de Lucas EM, et al. Cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS) with chronic cough and preserved muscle stretch reflexes: evidence for selective sparing of afferent Ia fibres. J Neurol. 2018;265(6):1454–62.
Ashizawa T, Oz G, Paulson HL. Spinocerebellar ataxias: prospects and challenges for therapy development. Nature Rev Neurol. 2018;14(10):590–605.
Bird T. Hereditary Ataxia Overview: GeneReviews®; 2019 [updated 2019 Jul 25; cited 2020 Mar 3]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1138/.
McLoughlin HS, Moore LR, Paulson HL. Pathogenesis of SCA3 and implications for other polyglutamine diseases. Neurobiol Dis. 2020;134:104635.
Martier R, Sogorb-Gonzalez M, Stricker-Shaver J, Hubener-Schmid J, Keskin S, Klima J, et al. Development of an AAV-based microRNA gene therapy to treat Machado-Joseph disease. Molecular therapy Methods & clinical development. 2019;15:343–58.
Szpisjak L, Zadori D, Klivenyi P, Vecsei L. Clinical characteristics and possible drug targets in autosomal dominant spinocerebellar ataxias. CNS Neurol Disord Drug TargetS. 2019;18(4):279–93.
Fesahat F, Montazeri F, Hoseini SM. Preimplantation genetic testing in assisted reproduction technology. J Gynecol Obstet Hum Reprod. 2020:101723.
Cahn S, Rosen A, Wilmot G. Spinocerebellar ataxia patient perceptions regarding reproductive options. Mov Disord Clin Pract. 2020;7(1):37–44.
Carroll LS, Massey TH, Wardle M, Peall KJ. Dentatorubral-pallidoluysian atrophy: an update. Tremor Other Hyperkinet Mov (N Y). 2018;8:577.
Burke JR, Wingfield MS, Lewis KE, Roses AD, Lee JE, Hulette C, et al. The Haw River syndrome: dentatorubropallidoluysian atrophy (DRPLA) in an African-American family. Nature Genet. 1994;7(4):521–4.
Rodriguez-Porcel F, Ciarlariello VB, Dwivedi AK, Lovera L, Da Prat G, Lopez-Castellanos R, et al. Movement disorders in prionopathies: a systematic review. Tremor Other Hyperkinet Mov (N Y). 2019;9.
Paucar M, Xiang F, Moore R, Walker R, Winnberg E, Svenningsson P. Genotype-phenotype analysis in inherited prion disease with eight octapeptide repeat insertional mutation. Prion. 2013;7(6):501–10.
Genis D, Ortega-Cubero S, San Nicolas H, Corral J, Gardenyes J, de Jorge L, et al. Heterozygous STUB1 mutation causes familial ataxia with cognitive affective syndrome (SCA48). Neurology. 2018;91(21):e1988–e98.
Hoche F, Guell X, Vangel MG, Sherman JC, Schmahmann JD. The cerebellar cognitive affective/Schmahmann syndrome scale. Brain : a. J Neurol. 2018;141(1):248–70.
De Michele G, Lieto M, Galatolo D, Salvatore E, Cocozza S, Barghigiani M, et al. Spinocerebellar ataxia 48 presenting with ataxia associated with cognitive, psychiatric, and extrapyramidal features: a report of two Italian families. Parkinsonism Relat Disord. 2019;65:91–6.
Hall DA, Berry-Kravis E. Fragile X syndrome and fragile X-associated tremor ataxia syndrome. Handb Clin Neurol. 2018;147:377–91.
Hall DA, Hagerman RJ. Fragile X-associated tremor/ataxia syndrome: unmet needs and a path for the future. Front Genet. 2018;9:100.
Finsterer J, Zarrouk-Mahjoub S. Mitochondrial multiorgan disorder syndrome score generated from definite mitochondrial disorders. Neuropsychiatr Dis Treat. 2017;13:2569–79.
Cohen BH, Chinnery PF, Copeland WC. POLG-Related Disorders. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, LJH B, Stephens K, et al., editors. GeneReviews((R)). Seattle: University of Washington.
Bargiela D, Shanmugarajah P, Lo C, Blakely EL, Taylor RW, Horvath R, et al. Mitochondrial pathology in progressive cerebellar ataxia. Cerebellum Ataxias. 2015;2:16.
Rahman S, Copeland WC. POLG-related disorders and their neurological manifestations. Nature Rev Neurol. 2019;15(1):40–52.
Yan C, Duanmu X, Zeng L, Liu B, Song Z. Mitochondrial DNA: distribution, mutations, and elimination. PLoS One. 2019;8(4).
Atorino L, Silvestri L, Koppen M, Cassina L, Ballabio A, Marconi R, et al. Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia. J Cell Biol. 2003;163(4):777–87.
Wedding IM, Koht J, Tran GT, Misceo D, Selmer KK, Holmgren A, et al. Spastic paraplegia type 7 is associated with multiple mitochondrial DNA deletions. PLoS one. 2014;9(1):e86340.
Coarelli G, Schule R, van de Warrenburg BPC, De Jonghe P, Ewenczyk C, Martinuzzi A, et al. Loss of paraplegin drives spasticity rather than ataxia in a cohort of 241 patients with SPG7. Neurology. 2019;92(23):e2679–e90.
Fadic R, Russell JA, Vedanarayanan VV, Lehar M, Kuncl RW, Johns DR. Sensory ataxic neuropathy as the presenting feature of a novel mitochondrial disease. Neurology. 1997;49(1):239–45.
Milone M, Massie R. Polymerase gamma 1 mutations: clinical correlations. Neurologist. 2010;16(2):84–91.
Set KK, Sen K, Huq AHM, Agarwal R. Mitochondrial disorders of the nervous system: a review. Clin Pediat. 2019;58(4):381–94.
Davison JE, Rahman S. Recognition, investigation and management of mitochondrial disease. Dis Child. 2017;102(11):1082–90.
North American Mitochondrial Disease Consortium: Rare disease clinical research network; 2020 [cited 2020 Mar 22]. Available from: https://www.rarediseasesnetwork.org/cms/namdc.
Eggink H, Kuiper A, Peall KJ, Contarino MF, Bosch AM, Post B, et al. Rare inborn errors of metabolism with movement disorders: a case study to evaluate the impact upon quality of life and adaptive functioning. Orphanet J Rare Dis. 2014;9:177.
Online Mendelian Inheritance in Man: An online catalog of human genes and genetic disorders Mar 2020 [updated Mar 19 2020]. Available from: https://www.ncbi.nlm.nih.gov/omim.
GTR: Genetic Testing Registry 8600 Rockville Pike, Bethesda MD, 20894 USA: National Center for Biotechnology Information, U.S. National Library of Medicine; 2020. Available from: https://www.ncbi.nlm.nih.gov/gtr/.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Movement Disorders
Rights and permissions
About this article
Cite this article
Witek, N., Hawkins, J. & Hall, D. Genetic ataxias: update on classification and diagnostic approaches. Curr Neurol Neurosci Rep 21, 13 (2021). https://doi.org/10.1007/s11910-021-01092-4
Accepted:
Published:
DOI: https://doi.org/10.1007/s11910-021-01092-4